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introduction: The presence of cardiovascular disease (CVD) is an important predictor of mortality in patients with renal disease. A paucity of data 
exists concerning the optimal method of coronary revascularization in patients with renal disease.
objective: We performed a meta- analysis to compare the risk of stroke in End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD) 
patients with CVD undergoing Coronary Artery Bypass Graft (CABG) or Percutaneous Coronary Intervention (PCI).
Methods:  Clinical trials evaluating the mortality in patients with ESRD and CKD undergoing CABG and PCI were considered. Studies were obtained 
using search words in Medline, Pubmed, EMBASE, CINAHL and Cochrane databases. The relative risk across all study groups was computed using Mantel-
Hanszel random effects model. Results were calculated with 95% CI and was considered statistically significant if 2-sided alpha error was <.05.
results:  Clinical outcomes in ESRD and CKD patients were analyzed separately. Fifteen trials (n= 53,579) were included for analysis in the ESRD 
group with average follow-up duration of 25 months. Five trials (n=14,768) were included in CKD arm. Mean age and follow-up duration were 65.5 
years and 36 months respectively. The relative risk for stroke in ESRD patients undergoing CABG when compared to PCI was 3.46 (1.02, 11.78); 
p=0.05)) and in CKD cohort was 0.78 (0.43, 1.41); p=0.41)).
conclusions:  There is a strong trend for decreased risk of stroke with PCI when compared to CABG in the ESRD group. Though PCI seems to be 
associated with a decreased risk for stroke in ESRD patients the results did not reach statistical significance. The risk for stroke with PCI and CABG is 
comparable in CKD patients. Prospective randomized studies that include cardio-metabolic markers in ESRD and CKD patients would be required to 
elucidate the pathophysiological mechanisms and risk for stroke in patients with different stages of renal failure.
